Enveric Biosciences shares are trading higher after the company announced it received a Notice of Allowance from the USPTO for a patent application involving its EVM201 Series.
Portfolio Pulse from Benzinga Newsdesk
Enveric Biosciences (ENVB) received a Notice of Allowance from the USPTO for a patent application involving its EVM201 Series, causing its shares to trade higher.
May 24, 2023 | 12:36 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Enveric Biosciences' shares are trading higher after receiving a Notice of Allowance from the USPTO for its EVM201 Series patent application.
The Notice of Allowance from the USPTO for Enveric Biosciences' EVM201 Series patent application is a positive development for the company. This news indicates that the company's intellectual property is being recognized and protected, which can lead to increased investor confidence and a higher stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100